Neuromuscular Genetic Diagnosis
-
Upload
vikki-stefans -
Category
Health & Medicine
-
view
1.604 -
download
8
description
Transcript of Neuromuscular Genetic Diagnosis
PROTOCOLS FOR NEUROMUSCULAR GENETIC DIAGNOSIS
…the easy problems have been solved already! (mostly)
OBJECTIVES
Review the pluses and minuses of the current diagnostic tools
Illuminate some pitfalls we might be able to fall into less often
Shorten and reduce costs of the diagnostic odyssey, while enhancing our likelihood of success and benefit for our patients
Make the case for a true interdisciplinary effort in neuromuscular diagnosis
WHAT’S WRONG WITH THIS PICTURE?
Credit: Jain Foundation, LGMD2I foundation
WHAT DIFFERENCE DOES IT MAKE?
Identify the medical risks Cardiac Pulmonary Anesthesia/malignant hyperthermia Diabetes, scoliosis, HCM Retinopathy, hearing loss
Genetic counseling accuracy XLR vs AR XLSD vs AD vs mito In some cases, clinical treatments or clinical trials may be
available depending on the specific genetic diagnosis Prognosis, what to expect/what helps, support groups
THE TOOLS FOR DIAGNOSIS - $
Family history Misdiagnosis, misreport, actually getting records
Physical exam Limited by cooperation UMN vs LMN, on a good day Cerebellar versus proprioceptive ataxia Muscle bulk, contracture, facial function, EOM, winging, microcephaly
Metabolic (non-genetic lab) tests Sometimes specific and quick. Sometimes not. CPK, aldolase, TFT AA, OA, isoelectric transferrin, CoQ10, vitamins Lactate/pyruvate – lots of false + and – Alpha-fetoprotein CSF studies
THE TOOLS FOR DIAGNOSIS – $$ Electrodiagnosis
Myopathic vs neuropathic, axonal vs demyelination Kids hate it. Especially repetitive stim, which is not always clear Myotonia is not as specific a finding as you’d like and may not be there in all
“myotonic” disorders May be a quick answer for floppy baby (SMA yes or no) UMN lesion can be confounding Very specific for compressive and radicular pathology
Biopsy More likely specific especially on immunostaining or EM Pitfalls with related protein staining affected May be nonspecific myopathic or even normal in some conditions Issues with specimens for send out – research vs clinical
Muscle Imaging Fatty infiltration vs inflammation Affected vs unaffected muscles
THE TOOLS FOR DIAGNOSIS – $$-$$$ Specific single gene tests
When common things occur commonly or single best explanation fits pretty well PANELS
The good, the bad and the ugly AVOID CMTD, HSP, SCA, DM – not supposed to be “orderable” here Some cover better than WES for specific conditions
Microarrays, snp arrays Yield about 15%, towards 20% Now requires consent Regions of homozygosity, duplications, deletions
Whole Exome Requires genetics consultation Expensive and not always covered for parent Best chance for diagnosis of rare condition if Brad Schaefer does not know
what it is off the top of his head Tool for discovery of new genes
From Prevention Genetics
http://preventiongenetics.com/files/6813/8619/3468/PricelistByDisease_11-15-13.pdf
CHARCOT MARIE TOOTH DISEASE(S)
Supect: Distal weakness, cavus, hypo or areflexia, Commonly +FH, “clumsy”
Options: Edx or PMP22 dup gene test alone first Typical, PN only, no need for other screenings
If atypical at all, CMT1x, MPZ, MFN also reasonable to do Edx for slow, very slow, or normal (demyelinating, intermediate, or
axonal) Partial panel vs whole exome
DO NOT GET THE FULL PANEL 1a-f = AD, demyelinating 2a-p = AD, axonal 4a-j = AR, demyelinating, internediate or axonal X1-5 (not 3a-e) “ ”
Mito and nuclear mito (e.g. PDH), HSANs, SCAs, leukodystrophies also cause hereditary neuropathy
NERVE BIOPSY??
Dejerine-Sottas not genetically specific PMP22, EGR2 (CMTD 1D, 4E), MPZ, PRX
Vasculitic, infectious or other acquired Sural (sensory) or epidermal for small-fiber Gene test might be better for amyloid (TTN)
Portugese variant 50% Fabry, Tangier, giant axonal neuropathy Reference:
http://archneur.jamanetwork.com/article.aspx?articleid=782848
DYSTROPHINOPATHY
Suspects Global delay in a boy as well as abnormal gait Elevated “LFT” no jaundice, alk phos, GGT OK Floppy baby with contiguous gene syndrome Rhabdmyolysis
CPK 4-5 figures, not clinically a myositis Utah dystrophinopathy (or other) gene test Leiden reading frame checker Clinicaltrials.gov Biopsies?
Research purposes Negative gene test
Edx not helpful
MYOTONIA
Suspects for myotonic dystrophy Clubfoot, floppy, facial weakness, global delay May be premie and look like or have CP also Adult with cataract, DM, low energy, temporal wasting
Myotonia not always present on Edx early At ACH – get only DM1 for number of repeats NOT PANEL
Myotonia Congenita is different disease Becker/Thomsen Strength low for degree of muscle bulk, warm-up CLCN1, SCN4a
Also consider Thyroid disorders Other channelopathies (e.g. KCNJ2/Tawil-Anderson short QT) Brody myopathy (ATP2a1) Some LGMD (especially 1c)
justsayno.
ANTERIOR HORN CELL DISEASE
Edx faster, should be confirmed
Rough correlation with SMN2 copies and severity
Biopsy may also be diagnostic, with group atrophy, not often required
Other rare conditions HBSMA SMARD DSMA - UE AMC
SCA, HSP
Friedreich’s ataxia (frataxin, not fragile X) Covered by MDA; others are generally not Cardiomyopathy, diabetes, scoliosis
Unless family history positive for specific gene,
Just say WES. (Just my $0.02)
TRANSITIONS Adhalin = alpha sarcoglycan SCARMD = sarcoglycanopathy or other LGMD2
High CPK with some dystrophin on biopsy ≠ Becker’s In 2006 had six genes for dystroglycanopathy, 50%
undiagnosed, now about 15 and fewer Some conditions caused by more than one gene Some genes cause more than one condition Conditions vary with what is wrong with the gene Some genes can cause disease as AR or AD Conditions vary depending on other genes What will we do when we run out of letters?
Only 6 more LGMDs to go…
CLASSIFICATIONS OF MUSCLE DISEASE
Congenital Myopathy Congenital Muscular Dystrophy
Collagen Related (Bethlem/Ullrich) Dystroglycanopathy Merosin-deficient and related Rigid spine SEPN, Integrins, etc.
Dystrophinopathy EDMD FSHMD Limb Girdle
Dominant, recessive, distal Myasthenia and myasthenic syndromes
EXAMPLE: LMNA Nuclear envelope gene, aka Lamin A/C Emery-Dreifuss muscular dystrophy
Scapuloperoneal, cardiac conduction concerns EDMD 2 and 3, AD (vs. SYNE1, SYNE2, FHL or x-linked with emerin)
LGMD1B AD “laminopathy” CMT2B1 AR
p.R644C missense mutation in the lamin A/C protein Familial partial lipodystrophy FPLD2 AD Dilated cardiomyopathy CMD1A Hutchinson-Gilford progeria
Due to farnesylated mutant prelamin A (progerin)
EXAMPLE: GLYCOSYLATION BUILDING CROSSWALKS
LGMD2I = MDDGC5 = MDC1C (FKRP) LGMD2K = MDDGC1 (POMT1) LGMD2N = MDDGC2 (POMT2) LGMD2O = MDDGC3 (POMGNT1) LGMD2M = MDDGC4 (FKTN)
Japanese severe form of CMD Compare with MDC1a, merosin aka alpha-laminin
LGMD2P = MDDGC9 (DAG1) LGMD2T = MDDGC14 (GMPPB) with/without ID, seizures
We have one case – U of Iowa fibroblast culture rescue technique Walker-Warburg can be several of the above Santavuori (MEB) “cobblestone” usually POMgnT1 “Partial merosin-deficient” likely in this group (MDC1B,D,E or new) CDGS
Classic with transferrin isoelectric focusing Overlap with dystroclycanopathy (DPMs) Brand new (PIGT) – we have two siblings, diagnosed by WES at NIH
GOOD FRIENDS HAVE TO STICK TOGETHER
LGMD & THE JAIN FOUNDATION TOOL
Primarily for LGMD2B, dysferlinopathy Concept is to determine probability and concordance based on
clinical evaluation, FH, CPK, optionally biopsy and brain MRI They got 45/50 if first position, 3/7 if 2 or 3
A route to free 2B or 2I testing Otherwise, great concept but does not quite work yet…
We got 1/12 specific (low concordance on a 2B) We got 4/12 dystroglycanopathy non-specific “definitively excluding conditions based on the presence or absence
of any one symptom isn't a good approach” Working on it, adding Pompe, DYS carrier, etc.
Automated LGMD Diagnostic Assistant (ALDA) http://jain-foundation.org/lgmd-subtyping-tool/content/login-tool
TWO “EASY” CASES
Young girl, brought in as affected DMD female due to biopsy with abnormal dystrophin after high CPK noted Dystrophin gene normal Phenotype merosin-deficient, confirmed genetically
Young man, looked like DMD Dystrophin gene normal, CPK 8,000 Immunostaining with reduced c-terminal dystrophin, COL6,
alpha-dystroglycan, abnormal dysferlin and caveolin pattern
Clinically not Bethlem-Ullrich, CNS near normal Selected LGMD2 gene tests, 2I was positive
TWO “OTHER” CASES
Two girls, one more severely affected Cataracts, club foot, intellectual disability Carrying diagnosis of AMC Genetics conference – consider DM1 vs WES Whole exome indicates CMT 2O (dynamin) Dynein defect reports more similar phenotype
but the two form a complex Mom is low level mosaic Edx (and publication?) pending…
THIS WENT RIGHT TO WES, RIGHTLY
Very severe Duchenne-like presentation 4 year old boy, weak from about 1 year of age,
progressing rapidly CPK only 264, lactate/pyruvate 21./1.6 Biopsy “mixed myopathic” normal
immunostaining WES had defect in thymidine kinase (TK2)
Autosomal recessive Might also have been found in ROH on snp array Mitochondrial DNA depletion, myopathic form
CONCLUSIONS
Single gene test if they walk in out of the textbook, or known diagnosis in family
Non-genetic tests where helpful to narrow it down Only a few of the panel tests make sense – ask Julie! – could it
really be ANY of the genes included? SNP array, mito sequencing may be first step especially if
consanguinity or dysmorphism WES if many possible categories, many possible genes, panels
more expensive NIH seems better than Mayo if we are still stuck (Mayo does not
take AR Medicaid) Genetics, genetic counselors, neuro, pathology, rehab can all
offer clues to differential diagnosis and management – what would happen if we put our heads together?
POST TEST (Easy – T/F)
Neuromuscular diagnosis should usually include a CPK
Neuromuscular diagnosis should always include electrodiagnosis and biopsy